Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immuno-Oncology Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Immune Checkpoint Inhibitors
1.2.3 Monoclonal Antibodies
1.2.4 Cytokine-Based Immunotherapy
1.2.5 Cancer Vaccines
1.2.6 CAR-T Cell Therapy
1.3 Market by Application
1.3.1 Global Immuno-Oncology Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Center
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Immuno-Oncology Treatment Market Perspective (2018-2033)
2.2 Immuno-Oncology Treatment Growth Trends by Region
2.2.1 Global Immuno-Oncology Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Immuno-Oncology Treatment Historic Market Size by Region (2018-2023)
2.2.3 Immuno-Oncology Treatment Forecasted Market Size by Region (2024-2033)
2.3 Immuno-Oncology Treatment Market Dynamics
2.3.1 Immuno-Oncology Treatment Industry Trends
2.3.2 Immuno-Oncology Treatment Market Drivers
2.3.3 Immuno-Oncology Treatment Market Challenges
2.3.4 Immuno-Oncology Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immuno-Oncology Treatment Players by Revenue
3.1.1 Global Top Immuno-Oncology Treatment Players by Revenue (2018-2023)
3.1.2 Global Immuno-Oncology Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Immuno-Oncology Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Immuno-Oncology Treatment Revenue
3.4 Global Immuno-Oncology Treatment Market Concentration Ratio
3.4.1 Global Immuno-Oncology Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immuno-Oncology Treatment Revenue in 2022
3.5 Immuno-Oncology Treatment Key Players Head office and Area Served
3.6 Key Players Immuno-Oncology Treatment Product Solution and Service
3.7 Date of Enter into Immuno-Oncology Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Immuno-Oncology Treatment Breakdown Data by Type
4.1 Global Immuno-Oncology Treatment Historic Market Size by Type (2018-2023)
4.2 Global Immuno-Oncology Treatment Forecasted Market Size by Type (2024-2033)
5 Immuno-Oncology Treatment Breakdown Data by Application
5.1 Global Immuno-Oncology Treatment Historic Market Size by Application (2018-2023)
5.2 Global Immuno-Oncology Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Immuno-Oncology Treatment Market Size (2018-2033)
6.2 North America Immuno-Oncology Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Immuno-Oncology Treatment Market Size by Country (2018-2023)
6.4 North America Immuno-Oncology Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Immuno-Oncology Treatment Market Size (2018-2033)
7.2 Europe Immuno-Oncology Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Immuno-Oncology Treatment Market Size by Country (2018-2023)
7.4 Europe Immuno-Oncology Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Immuno-Oncology Treatment Market Size (2018-2033)
8.2 Asia-Pacific Immuno-Oncology Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Immuno-Oncology Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Immuno-Oncology Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Immuno-Oncology Treatment Market Size (2018-2033)
9.2 Latin America Immuno-Oncology Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Immuno-Oncology Treatment Market Size by Country (2018-2023)
9.4 Latin America Immuno-Oncology Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immuno-Oncology Treatment Market Size (2018-2033)
10.2 Middle East & Africa Immuno-Oncology Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Immuno-Oncology Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Immuno-Oncology Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Detail
11.1.2 Amgen Business Overview
11.1.3 Amgen Immuno-Oncology Treatment Introduction
11.1.4 Amgen Revenue in Immuno-Oncology Treatment Business (2018-2023)
11.1.5 Amgen Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Detail
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Immuno-Oncology Treatment Introduction
11.2.4 AstraZeneca Revenue in Immuno-Oncology Treatment Business (2018-2023)
11.2.5 AstraZeneca Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Detail
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Immuno-Oncology Treatment Introduction
11.3.4 Bristol-Myers Squibb Revenue in Immuno-Oncology Treatment Business (2018-2023)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 Eli-Lilly
11.4.1 Eli-Lilly Company Detail
11.4.2 Eli-Lilly Business Overview
11.4.3 Eli-Lilly Immuno-Oncology Treatment Introduction
11.4.4 Eli-Lilly Revenue in Immuno-Oncology Treatment Business (2018-2023)
11.4.5 Eli-Lilly Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche Immuno-Oncology Treatment Introduction
11.5.4 Roche Revenue in Immuno-Oncology Treatment Business (2018-2023)
11.5.5 Roche Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Detail
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline Immuno-Oncology Treatment Introduction
11.6.4 GlaxoSmithKline Revenue in Immuno-Oncology Treatment Business (2018-2023)
11.6.5 GlaxoSmithKline Recent Development
11.7 Janssen Biotech
11.7.1 Janssen Biotech Company Detail
11.7.2 Janssen Biotech Business Overview
11.7.3 Janssen Biotech Immuno-Oncology Treatment Introduction
11.7.4 Janssen Biotech Revenue in Immuno-Oncology Treatment Business (2018-2023)
11.7.5 Janssen Biotech Recent Development
11.8 Merck
11.8.1 Merck Company Detail
11.8.2 Merck Business Overview
11.8.3 Merck Immuno-Oncology Treatment Introduction
11.8.4 Merck Revenue in Immuno-Oncology Treatment Business (2018-2023)
11.8.5 Merck Recent Development
11.9 Novartis
11.9.1 Novartis Company Detail
11.9.2 Novartis Business Overview
11.9.3 Novartis Immuno-Oncology Treatment Introduction
11.9.4 Novartis Revenue in Immuno-Oncology Treatment Business (2018-2023)
11.9.5 Novartis Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Detail
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Immuno-Oncology Treatment Introduction
11.10.4 Pfizer Revenue in Immuno-Oncology Treatment Business (2018-2023)
11.10.5 Pfizer Recent Development
11.11 Sanofi
11.11.1 Sanofi Company Detail
11.11.2 Sanofi Business Overview
11.11.3 Sanofi Immuno-Oncology Treatment Introduction
11.11.4 Sanofi Revenue in Immuno-Oncology Treatment Business (2018-2023)
11.11.5 Sanofi Recent Development
11.12 Spectrum Pharmaceuticals
11.12.1 Spectrum Pharmaceuticals Company Detail
11.12.2 Spectrum Pharmaceuticals Business Overview
11.12.3 Spectrum Pharmaceuticals Immuno-Oncology Treatment Introduction
11.12.4 Spectrum Pharmaceuticals Revenue in Immuno-Oncology Treatment Business (2018-2023)
11.12.5 Spectrum Pharmaceuticals Recent Development
11.13 Takeda
11.13.1 Takeda Company Detail
11.13.2 Takeda Business Overview
11.13.3 Takeda Immuno-Oncology Treatment Introduction
11.13.4 Takeda Revenue in Immuno-Oncology Treatment Business (2018-2023)
11.13.5 Takeda Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Immuno-Oncology Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Immune Checkpoint Inhibitors
Table 3. Key Players of Monoclonal Antibodies
Table 4. Key Players of Cytokine-Based Immunotherapy
Table 5. Key Players of Cancer Vaccines
Table 6. Key Players of CAR-T Cell Therapy
Table 7. Global Immuno-Oncology Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Immuno-Oncology Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Immuno-Oncology Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Immuno-Oncology Treatment Market Share by Region (2018-2023)
Table 11. Global Immuno-Oncology Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Immuno-Oncology Treatment Market Share by Region (2024-2033)
Table 13. Immuno-Oncology Treatment Market Trends
Table 14. Immuno-Oncology Treatment Market Drivers
Table 15. Immuno-Oncology Treatment Market Challenges
Table 16. Immuno-Oncology Treatment Market Restraints
Table 17. Global Immuno-Oncology Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Immuno-Oncology Treatment Market Share by Players (2018-2023)
Table 19. Global Top Immuno-Oncology Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-Oncology Treatment as of 2022)
Table 20. Ranking of Global Top Immuno-Oncology Treatment Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Immuno-Oncology Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Immuno-Oncology Treatment Product Solution and Service
Table 24. Date of Enter into Immuno-Oncology Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Immuno-Oncology Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Immuno-Oncology Treatment Revenue Market Share by Type (2018-2023)
Table 28. Global Immuno-Oncology Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Immuno-Oncology Treatment Revenue Market Share by Type (2024-2033)
Table 30. Global Immuno-Oncology Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Immuno-Oncology Treatment Revenue Market Share by Application (2018-2023)
Table 32. Global Immuno-Oncology Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Immuno-Oncology Treatment Revenue Market Share by Application (2024-2033)
Table 34. North America Immuno-Oncology Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. North America Immuno-Oncology Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Immuno-Oncology Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 37. Europe Immuno-Oncology Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. Europe Immuno-Oncology Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Immuno-Oncology Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 40. Asia-Pacific Immuno-Oncology Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 41. Asia-Pacific Immuno-Oncology Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Immuno-Oncology Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 43. Latin America Immuno-Oncology Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Latin America Immuno-Oncology Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Immuno-Oncology Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 46. Middle East & Africa Immuno-Oncology Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Middle East & Africa Immuno-Oncology Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Immuno-Oncology Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 49. Amgen Company Detail
Table 50. Amgen Business Overview
Table 51. Amgen Immuno-Oncology Treatment Product
Table 52. Amgen Revenue in Immuno-Oncology Treatment Business (2018-2023) & (US$ Million)
Table 53. Amgen Recent Development
Table 54. AstraZeneca Company Detail
Table 55. AstraZeneca Business Overview
Table 56. AstraZeneca Immuno-Oncology Treatment Product
Table 57. AstraZeneca Revenue in Immuno-Oncology Treatment Business (2018-2023) & (US$ Million)
Table 58. AstraZeneca Recent Development
Table 59. Bristol-Myers Squibb Company Detail
Table 60. Bristol-Myers Squibb Business Overview
Table 61. Bristol-Myers Squibb Immuno-Oncology Treatment Product
Table 62. Bristol-Myers Squibb Revenue in Immuno-Oncology Treatment Business (2018-2023) & (US$ Million)
Table 63. Bristol-Myers Squibb Recent Development
Table 64. Eli-Lilly Company Detail
Table 65. Eli-Lilly Business Overview
Table 66. Eli-Lilly Immuno-Oncology Treatment Product
Table 67. Eli-Lilly Revenue in Immuno-Oncology Treatment Business (2018-2023) & (US$ Million)
Table 68. Eli-Lilly Recent Development
Table 69. Roche Company Detail
Table 70. Roche Business Overview
Table 71. Roche Immuno-Oncology Treatment Product
Table 72. Roche Revenue in Immuno-Oncology Treatment Business (2018-2023) & (US$ Million)
Table 73. Roche Recent Development
Table 74. GlaxoSmithKline Company Detail
Table 75. GlaxoSmithKline Business Overview
Table 76. GlaxoSmithKline Immuno-Oncology Treatment Product
Table 77. GlaxoSmithKline Revenue in Immuno-Oncology Treatment Business (2018-2023) & (US$ Million)
Table 78. GlaxoSmithKline Recent Development
Table 79. Janssen Biotech Company Detail
Table 80. Janssen Biotech Business Overview
Table 81. Janssen Biotech Immuno-Oncology Treatment Product
Table 82. Janssen Biotech Revenue in Immuno-Oncology Treatment Business (2018-2023) & (US$ Million)
Table 83. Janssen Biotech Recent Development
Table 84. Merck Company Detail
Table 85. Merck Business Overview
Table 86. Merck Immuno-Oncology Treatment Product
Table 87. Merck Revenue in Immuno-Oncology Treatment Business (2018-2023) & (US$ Million)
Table 88. Merck Recent Development
Table 89. Novartis Company Detail
Table 90. Novartis Business Overview
Table 91. Novartis Immuno-Oncology Treatment Product
Table 92. Novartis Revenue in Immuno-Oncology Treatment Business (2018-2023) & (US$ Million)
Table 93. Novartis Recent Development
Table 94. Pfizer Company Detail
Table 95. Pfizer Business Overview
Table 96. Pfizer Immuno-Oncology Treatment Product
Table 97. Pfizer Revenue in Immuno-Oncology Treatment Business (2018-2023) & (US$ Million)
Table 98. Pfizer Recent Development
Table 99. Sanofi Company Detail
Table 100. Sanofi Business Overview
Table 101. Sanofi Immuno-Oncology Treatment Product
Table 102. Sanofi Revenue in Immuno-Oncology Treatment Business (2018-2023) & (US$ Million)
Table 103. Sanofi Recent Development
Table 104. Spectrum Pharmaceuticals Company Detail
Table 105. Spectrum Pharmaceuticals Business Overview
Table 106. Spectrum Pharmaceuticals Immuno-Oncology Treatment Product
Table 107. Spectrum Pharmaceuticals Revenue in Immuno-Oncology Treatment Business (2018-2023) & (US$ Million)
Table 108. Spectrum Pharmaceuticals Recent Development
Table 109. Takeda Company Detail
Table 110. Takeda Business Overview
Table 111. Takeda Immuno-Oncology Treatment Product
Table 112. Takeda Revenue in Immuno-Oncology Treatment Business (2018-2023) & (US$ Million)
Table 113. Takeda Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immuno-Oncology Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Immuno-Oncology Treatment Market Share by Type: 2022 VS 2033
Figure 3. Immune Checkpoint Inhibitors Features
Figure 4. Monoclonal Antibodies Features
Figure 5. Cytokine-Based Immunotherapy Features
Figure 6. Cancer Vaccines Features
Figure 7. CAR-T Cell Therapy Features
Figure 8. Global Immuno-Oncology Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 9. Global Immuno-Oncology Treatment Market Share by Application: 2022 VS 2033
Figure 10. Hospitals Case Studies
Figure 11. Ambulatory Surgical Center Case Studies
Figure 12. Others Case Studies
Figure 13. Immuno-Oncology Treatment Report Years Considered
Figure 14. Global Immuno-Oncology Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global Immuno-Oncology Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global Immuno-Oncology Treatment Market Share by Region: 2022 VS 2033
Figure 17. Global Immuno-Oncology Treatment Market Share by Players in 2022
Figure 18. Global Top Immuno-Oncology Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-Oncology Treatment as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Immuno-Oncology Treatment Revenue in 2022
Figure 20. North America Immuno-Oncology Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America Immuno-Oncology Treatment Market Share by Country (2018-2033)
Figure 22. United States Immuno-Oncology Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Immuno-Oncology Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Immuno-Oncology Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Immuno-Oncology Treatment Market Share by Country (2018-2033)
Figure 26. Germany Immuno-Oncology Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France Immuno-Oncology Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. Immuno-Oncology Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy Immuno-Oncology Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia Immuno-Oncology Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries Immuno-Oncology Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Immuno-Oncology Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Immuno-Oncology Treatment Market Share by Region (2018-2033)
Figure 34. China Immuno-Oncology Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Japan Immuno-Oncology Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. South Korea Immuno-Oncology Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Southeast Asia Immuno-Oncology Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. India Immuno-Oncology Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Australia Immuno-Oncology Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Immuno-Oncology Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Immuno-Oncology Treatment Market Share by Country (2018-2033)
Figure 42. Mexico Immuno-Oncology Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Brazil Immuno-Oncology Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Immuno-Oncology Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Immuno-Oncology Treatment Market Share by Country (2018-2033)
Figure 46. Turkey Immuno-Oncology Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Saudi Arabia Immuno-Oncology Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Amgen Revenue Growth Rate in Immuno-Oncology Treatment Business (2018-2023)
Figure 49. AstraZeneca Revenue Growth Rate in Immuno-Oncology Treatment Business (2018-2023)
Figure 50. Bristol-Myers Squibb Revenue Growth Rate in Immuno-Oncology Treatment Business (2018-2023)
Figure 51. Eli-Lilly Revenue Growth Rate in Immuno-Oncology Treatment Business (2018-2023)
Figure 52. Roche Revenue Growth Rate in Immuno-Oncology Treatment Business (2018-2023)
Figure 53. GlaxoSmithKline Revenue Growth Rate in Immuno-Oncology Treatment Business (2018-2023)
Figure 54. Janssen Biotech Revenue Growth Rate in Immuno-Oncology Treatment Business (2018-2023)
Figure 55. Merck Revenue Growth Rate in Immuno-Oncology Treatment Business (2018-2023)
Figure 56. Novartis Revenue Growth Rate in Immuno-Oncology Treatment Business (2018-2023)
Figure 57. Pfizer Revenue Growth Rate in Immuno-Oncology Treatment Business (2018-2023)
Figure 58. Sanofi Revenue Growth Rate in Immuno-Oncology Treatment Business (2018-2023)
Figure 59. Spectrum Pharmaceuticals Revenue Growth Rate in Immuno-Oncology Treatment Business (2018-2023)
Figure 60. Takeda Revenue Growth Rate in Immuno-Oncology Treatment Business (2018-2023)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed